|Therapeutic Class:||Anti-fibrinolytic drugs|
|Manufacturer:||Nuvista Pharma Ltd.|
|Last Updated:||2020-11-19 18:15:00|
Anaroxyl Injection contains Adrenochrome Monosemicarbazone. Anaroxyl uses:
Adrenochrome is indicated in control capillary bleeding, haemoptysis, epistemic, haematuria, retinal hemorrhage, secondary hemorrhage from wounds
Anaroxyl Injection contains Adrenochrome Monosemicarbazone 5 mg/ml. Anaroxyl doses:
Injection (Child <6 years): 1-2 ml tid.
Allergic reactions may occur like dyspnoea, bronchospasm, skin reaction etc.
Adrenochrome Monosemicarbazone is a haemostatic with a rapid onset of action. It contains a water soluble form of adrenochrome monosemicarbazone, a stable derivative of adrenochrome as the active substance. Adrenochrome is an oxidation product of adrenaline; it reduces normal and pathologic bleeding time by decreasing capillary permeability. It produces capillary haemostatis without exerting any of the adrenergic actions on respiration or cardiovascular system. Thus, despite its adrenaline like action on small blood vessels, does not give rise to the general systemic effects of sympathomimetic drugs.
Because of the content of diprophylline (90 mg/ml), the dosage to premature babies, infants and young children should not exceed 0.3 ml.
No specific drug interaction has been demonstrated.
Pregnancy Category-Not Classified. FDA has not yet classified the drug into a specified pregnancy category
Should not be administered to patients with hypersensitivity
Anaroxyl Injection price in Bangladesh 27.57